XIENCE™ Family of Drug-Eluting Stents

The World's Leading Drug-Eluting Stents (DES), with Unparalleled Clinical Outcomes¹

XIENCE™ Family of Drug-Eluting Stents

XIENCE Sierra™ Stent — Best In-Class Deliverability2

The XIENCE Sierra™ stent design offers unmatched deliverability, even when treating challenging complex lesions.

Less Force Required to Cross Lesions

XIENCE Sierra™ Stent requires less force than competitors when crossing a lesion:
73% less force than Synergy and 64% less force than Resolute Onyx

XIENCE Sierra requires 73% less force to cross lesion than Synergy, 64% less force than Resolute Onyx.

Tighter Crimping For Smoother Crossing2

The optimised MULTI-LINK design enables tighter crimping with XIENCE Sierra™ Stent, allowing for smoother crossing.

XIENCE Sierra has a narrower crest and slimmer, more flexible links—allowing for smoother crossing.

Thinner Balloon for Flexibility in Crossing2

The stent design and thinner balloon technology enhance flexibility and further lower the crimped profile. Among the other features allowing for excellent deliverability is a single-piece outer member for added pushability and trackability.

XIENCE Sierra Stent has a thinner balloon, allowing even lower crimped profile.

 

Ultra Low Stent Crossing Profile of 0.039"2

The ultra low stent crossing profile, at 0.039", is another factor enabling ease of crossing.

XIENCE DES has an ultra low crossing profile compared to competitors.

More XIENCE Sierra™ Stent features

Explore Abbott's technologies for your needs.

Explore Abbott's technologies for your needs.

Access personalised education and training

Access personalised education and training

How can we help? Reach Abbott’s fast support here.

How can we help? Reach Abbott’s fast support here.

References

  1. Zanchin C, et al. JACC Cardiovasc Interv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Shiomi H, et al. JACC Cardiovasc Interv. 2019;12:637-647. Kufner S, et al. Circulation. 2019:139(3):325-333. Palmerini T, et al. Lancet. 2013;379:1393-1402. Bangalore S, et al. Circulation. 2012;125:2873-2891. Bangalore S, et al. Circ Cardiovasc Interv. 2013;6(6):378-390. Pilgrim T, et al. Lancet. 2014;384:2111-2122. Pilgrim T, et al. Lancet. 2018;392:737-746. Data on file at Abbott.
  2. Data on file at Abbott. XIENCE Sierra™ Stent (3.0 x 18 mm, n=5), SYNERGY (3.0 x 20 mm, n=5), Resolute Onyx (3.0 x 18 mm, n=5). Bench test results may not necessarily be indicative of clinical performance. Note: XIENCE Sierra™ Stent showed better crossability with no difference in trackability and pushability compared to Resolute Onyx and SYNERGY Stents. Catheter performance crossability test measures average force to cross a challenging lesion model.

MAT-2413507 V1.0